USFDA completes inspection at facility of Granules India’s arm
28th Jun 2021

United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India located in Chantilly, Virginia, USA on June 25, 2021 with two minor observations. This is a pre-approval inspection for the products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).